Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$0.66 - $0.91 $330 - $455
-500 Reduced 33.56%
990 $0
Q2 2023

Aug 08, 2023

SELL
$1.12 - $1.49 $672 - $894
-600 Reduced 28.71%
1,490 $1,000
Q1 2023

Apr 25, 2023

SELL
$1.19 - $2.19 $29,452 - $54,202
-24,750 Reduced 92.21%
2,090 $3,000
Q4 2022

Jan 30, 2023

SELL
$1.07 - $1.34 $749 - $938
-700 Reduced 2.54%
26,840 $32,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $6,114 - $9,368
-5,610 Reduced 16.92%
27,540 $30,000
Q2 2022

Jul 22, 2022

BUY
$1.13 - $3.69 $932 - $3,044
825 Added 2.55%
33,150 $49,000
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $19,380 - $25,364
-6,800 Reduced 17.38%
32,325 $106,000
Q4 2021

Feb 09, 2022

SELL
$3.24 - $5.18 $307,962 - $492,359
-95,050 Reduced 70.84%
39,125 $131,000
Q3 2021

Nov 09, 2021

BUY
$3.94 - $5.84 $15,169 - $22,484
3,850 Added 2.95%
134,175 $685,000
Q2 2021

Jul 08, 2021

SELL
$4.26 - $6.5 $6,177 - $9,425
-1,450 Reduced 1.1%
130,325 $572,000
Q4 2020

May 19, 2021

SELL
$4.04 - $5.31 $41,874 - $55,038
-10,365 Reduced 7.29%
131,775 $794,000
Q3 2020

Sep 07, 2021

BUY
$3.64 - $7.76 $4,914 - $10,476
1,350 Added 0.96%
142,140 $541,000
Q2 2020

Sep 07, 2021

BUY
$4.78 - $8.26 $274,850 - $474,950
57,500 Added 69.04%
140,790 $943,000
Q1 2020

Sep 07, 2021

BUY
$4.0 - $21.53 $139,188 - $749,179
34,797 Added 71.76%
83,290 $1.1 Million
Q4 2019

Sep 07, 2021

BUY
$13.94 - $24.12 $468,523 - $810,673
33,610 Added 225.83%
48,493 $1.05 Million
Q3 2019

Sep 07, 2021

BUY
$13.89 - $23.16 $5,000 - $8,337
360 Added 2.48%
14,883 $225,000
Q2 2019

Sep 07, 2021

BUY
$16.27 - $20.51 $164,375 - $207,212
10,103 Added 228.57%
14,523 $281,000
Q1 2019

Sep 07, 2021

BUY
$12.61 - $22.33 $11,727 - $20,766
930 Added 26.65%
4,420 $91,000
Q4 2018

Sep 07, 2021

SELL
$12.41 - $22.98 $9,307 - $17,235
-750 Reduced 17.69%
3,490 $46,000
Q3 2018

Sep 07, 2021

BUY
$2.45 - $16.27 $588 - $3,904
240 Added 6.0%
4,240 $68,000
Q2 2018

Sep 07, 2021

SELL
$2.68 - $3.48 $643 - $835
-240 Reduced 5.66%
4,000 $12,000
Q3 2017

Sep 07, 2021

BUY
$3.03 - $3.72 $1,515 - $1,860
500 Added 13.37%
4,240 $14,000
Q1 2016

Sep 07, 2021

BUY
N/A
3,740
3,740 $5,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.